Free Trial

Fortress Biotech (FBIO) Competitors

Fortress Biotech logo
$1.97 +0.03 (+1.55%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.97 0.00 (0.00%)
As of 07/25/2025 05:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FBIO vs. AGEN, IRWD, SGMO, ACHV, DOMH, SABS, CRIS, BOLT, AMGN, and GILD

Should you be buying Fortress Biotech stock or one of its competitors? The main competitors of Fortress Biotech include Agenus (AGEN), Ironwood Pharmaceuticals (IRWD), Sangamo Therapeutics (SGMO), Achieve Life Sciences (ACHV), Dominari (DOMH), SAB Biotherapeutics (SABS), Curis (CRIS), Bolt Biotherapeutics (BOLT), Amgen (AMGN), and Gilead Sciences (GILD). These companies are all part of the "biotechnology" industry.

Fortress Biotech vs. Its Competitors

Fortress Biotech (NASDAQ:FBIO) and Agenus (NASDAQ:AGEN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Fortress Biotech has higher earnings, but lower revenue than Agenus. Fortress Biotech is trading at a lower price-to-earnings ratio than Agenus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$57.67M1.01-$46M-$2.23-0.88
Agenus$103.46M1.58-$227.21M-$8.67-0.69

96.5% of Fortress Biotech shares are owned by institutional investors. Comparatively, 61.5% of Agenus shares are owned by institutional investors. 27.9% of Fortress Biotech shares are owned by company insiders. Comparatively, 5.5% of Agenus shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Agenus had 1 more articles in the media than Fortress Biotech. MarketBeat recorded 3 mentions for Agenus and 2 mentions for Fortress Biotech. Fortress Biotech's average media sentiment score of 0.94 beat Agenus' score of 0.62 indicating that Fortress Biotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fortress Biotech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Agenus
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fortress Biotech presently has a consensus target price of $21.00, indicating a potential upside of 965.99%. Agenus has a consensus target price of $16.33, indicating a potential upside of 174.05%. Given Fortress Biotech's stronger consensus rating and higher possible upside, analysts plainly believe Fortress Biotech is more favorable than Agenus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fortress Biotech
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Agenus
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Fortress Biotech has a net margin of -71.24% compared to Agenus' net margin of -196.12%. Agenus' return on equity of 0.00% beat Fortress Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Fortress Biotech-71.24% -4,712.53% -27.67%
Agenus -196.12%N/A -82.33%

Fortress Biotech has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500. Comparatively, Agenus has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500.

Summary

Fortress Biotech beats Agenus on 10 of the 15 factors compared between the two stocks.

Get Fortress Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBIO vs. The Competition

MetricFortress BiotechMED IndustryMedical SectorNASDAQ Exchange
Market Cap$57.37M$3.05B$5.70B$9.50B
Dividend YieldN/A2.37%4.58%4.01%
P/E Ratio-0.8821.3228.4120.08
Price / Sales1.01285.38432.3189.32
Price / CashN/A42.7636.2258.56
Price / Book-32.838.378.675.88
Net Income-$46M-$55.19M$3.25B$258.89M
7 Day Performance1.03%5.86%4.25%3.71%
1 Month Performance6.49%17.29%10.51%11.72%
1 Year Performance-12.44%4.39%35.68%18.01%

Fortress Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBIO
Fortress Biotech
2.5057 of 5 stars
$1.97
+1.5%
$21.00
+966.0%
-24.2%$57.37M$57.67M-0.88170
AGEN
Agenus
4.219 of 5 stars
$6.09
-1.0%
$16.33
+168.2%
-0.1%$168.61M$103.46M-0.70440Positive News
IRWD
Ironwood Pharmaceuticals
4.3673 of 5 stars
$0.76
-0.5%
$4.78
+526.6%
-88.0%$124.20M$351.41M-3.82220Positive News
SGMO
Sangamo Therapeutics
2.3932 of 5 stars
$0.49
-3.1%
$4.50
+809.8%
-12.9%$118.96M$57.80M0.00480Positive News
ACHV
Achieve Life Sciences
2.8069 of 5 stars
$2.66
-0.7%
$14.33
+438.8%
-45.2%$92.96MN/A-1.9920High Trading Volume
DOMH
Dominari
1.0874 of 5 stars
$5.22
-3.2%
N/A+181.1%$78.93M$18.15M-1.164
SABS
SAB Biotherapeutics
3.6868 of 5 stars
$2.70
+5.1%
$13.25
+390.7%
-7.6%$23.87M$1.32M-0.73140News Coverage
Analyst Forecast
Analyst Revision
Gap Up
High Trading Volume
CRIS
Curis
2.5717 of 5 stars
$1.74
-3.3%
$17.00
+877.0%
-69.4%$18.83M$10.91M-0.2860Positive News
Upcoming Earnings
BOLT
Bolt Biotherapeutics
2.7101 of 5 stars
$5.74
+3.8%
$50.00
+771.1%
-57.1%$10.60M$7.69M-0.1790Positive News
High Trading Volume
AMGN
Amgen
4.3994 of 5 stars
$295.87
+0.4%
$308.32
+4.2%
-8.3%$158.49B$33.42B27.0028,000Positive News
Analyst Forecast
GILD
Gilead Sciences
4.886 of 5 stars
$108.28
+0.1%
$111.38
+2.9%
+51.9%$134.62B$28.75B13.9817,600Trending News
Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:FBIO) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners